contadores
Ir al menú de navegación principal Ir al contenido principal Ir al pie de página del sitio
##common.pageHeaderLogo.altText##

Research Article

Vol. 43 Núm. 1 (2026): Revista de Ciencias Agrícolas - enero - abril 2026

Plant secondary metabolites against Candida auris: mechanisms and evidence

DOI
https://doi.org/10.22267/rcia.2026431.295
Enviado
marzo 3, 2026
Publicado
2026-04-30

Resumen

Candida auris is an emerging multidrug-resistant fungal pathogen that poses a significant public health threat. This fungus has spread to more than 30 countries. This review was conducted aiming to search for in vitro studies on the antifungal actions of plant metabolites against C. auris. The review was constructed following the guidelines of the PRISMA statement. The research protocol was registered on the PROSPERO platform. A literature search was performed in the PubMed, Scopus, and Virtual Health Library databases, with no restrictions on year or language. Eligibility criteria were based on the PICO concept. Data were meta-analyzed using R software. The risk of bias assessment was performed using an adaptation of the CONSORT tool. A total of 11 of the 768 articles were included in the systematic review and meta-analysis, and 30 secondary metabolites of plant origin were analyzed. Of the 30 metabolites found, 26 presented results similar to the controls, and 4 showed superior results: palm leaf extract, Syzygium samarangense bark, Cinnamomum zeylanicum oil (bark) and Cinnamomum zeylanicum (leaf). Most plant secondary metabolites showed excellent antifungal potential against C. auris. As a limitation of the study, metabolites of very heterogeneous origin, extraction method, and distinct controls were grouped, which may have interfered with the interpretation of the results, increasing the risk of bias and imprecision. Therefore, further research is needed to confirm their clinical efficacy and safety and elucidate the mechanisms of action.

 

Citas

  1. Ahmad, S., & Alfouzan, W. (2021). Candida auris: epidemiology, diagnosis, pathogenesis, antifungal susceptibility, and infection control measures to combat the spread of infections in healthcare facilities. Microorganisms, 9, 807. https://doi.org/10.3390/microorganisms9040807
  2. Akhtar, N., Mannan, M. A., Pandey, D., Sarkar, A., Sharma, H., Kumar, M., & Ghosh, A. (2023). Potent antifungal properties of gallic acid in Sarcochlamys pulcherrima against Candida auris. BioTechnologia (Pozn), 104(2), 105. https://doi.org/10.5114/bta.2023.127202
  3. Alshahrani, M. Y., Ibrahim, E. H., Asiri, M., Kilany, M., Alshehri, A., Alkhathami, A. G., Morsy, K., & Chandramoorthy, H. C. (2022). Inhibition realization of multidrug resistant bacterial and fungal isolates using Coccinia indica extracts. Saudi Journal of Biological Sciences, 29(5), 3207-3212. https://doi.org/10.1016/j.sjbs.2022.01.045
  4. Banik, S. (2023). Editorial: Candida auris - understanding the new superbug. Front. Cell. Infect. Microbiol, 13, 1241623. https://doi.org/10.3389/fcimb.2023.1241623
  5. Benedict, K., Forsberg, K., Gold, J. A. W., Baggs, J., & Lyman, M. (2023). Candida auris‒associated hospitalizations, United States, 2017–2022. Emerging Infectious Diseases. 29(7), 1485. https://doi.org/10.3201/eid2907.230540
  6. Booth A., Clarke, M., Dooley, G., Ghersi D., Moher, D., Petticrew, M., & Stewart, L. (2012) The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Systematic Reviews, 1, 2.
  7. Bravo-Chaucanés, C. P., Vargas-Casanova, Y., Chitiva-Chitiva, L. C., Ceballos-Garzon, A., Modesti-Costa, G., & Parra-Giraldo, C. M. (2022). Evaluation of anti-Candida potential of Piper nigrum extract in inhibiting growth, yeast-hyphal transition, virulent enzymes, and biofilm formation. Journal of Fungi (Basel), 8(8), 784. https://doi.org/10.3390/jof8080784
  8. Chowdhary, A., Jain, K., & Chauhan, N. (2023). Candida auris genetics and emergence. Annual Review of Microbiology, 77, 583-602. https://doi.org/10.1146/annurev-micro-032521-015858
  9. Di Vito, M., Garzoli, S., Rosato, R., Mariotti, M., Gervasoni, J., Santucci, L., Ovidi, E., Cacaci, M., Lombarini, G., Torelli, R., Urbani, A., & Bugli, M. (2023). A new potential resource in the fight against Candida auris: the Cinnamomum zeylanicum essential oil in synergy with antifungal drug. Microbiology Spectrum, 11(2), e04385-22. https://doi.org/10.1128/spectrum.04385-22
  10. Eldesouky, H. E., Lanman, N. A., Hazbun, T. R., & Seleem, M. N. (2020). Aprepitant, an antiemetic agent, interferes with metal ion homeostasis of Candida auris and displays potent synergistic interactions with azole drugs. Virulence, 11(1), 1466–1481. https://doi.org/10.1080/21505594.2020.1838741
  11. Fatima, H., Syed, A. M., Riaz, F., Rangwala, B. S., & Rangwala, H. S. (2023). Candida auris: a growing threat to global health. IJS Global Health, 6(4), e0183. http://dx.doi.org/10.1097/GH9.0000000000000183
  12. Ferreira, E. S., Rosalen, P. L., Benso, B., Sardi, J. C. O., Denny, C., Sousa, S. A., Guerra, F. Q. S., Lima, O. E., Freires, I. A., & Castro, R. D. (2021). The use of essential oils and their isolated compounds for the treatment of oral candidiasis: a literature review. Evidence-Based Complementary and Alternative Medicine, 2021, 059274. https://doi.org/10.1155/2021/1059274
  13. Ferreira, O. O., Silva, S. H. M., Oliveira, M. S., & Andrade, E. H. A. (2021). Chemical composition and antifungal activity of Myrcia multiflora and Eugenia florida essential oils. Molecules, 26(23), 7259. https://doi.org/10.3390/molecules26237259
  14. Fisher, M. C., Henk, D. A., Briggs, C. J., Brownstein, J. S., Madoff, L. C., McCraw, S. L., & Gurr, S. J. (2012). Emerging fungal threats to animal, plant and ecosystem health. Nature, 484(7393), 186-194. https://doi.org/10.1038/nature10947
  15. Higgins, J. P., & Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21(11), 1539-1558. https://doi.org/10.1002/sim.1186
  16. Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ, 327(7414), 557-560. https://doi.org/10.1136/bmj.327.7414.557
  17. Huang, X., Hurabielle, C., Drummond, R. B., Bouladoux, N., Desai, J. V., Sim, C. K., Belkaid, Y., Lionakis, M. S., & Segre, J. A. (2020). Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and therapeutic strategies. Cell Host & Microbe, 29, 210-221.e6. https://doi.org/10.1016/j.chom.2020.12.002
  18. Kamli, M. R., Srivastava, V., Hajrah, N. H., Sabir, J. S. M., Ali, A., Malik, M. A., & Ahmad, A. (2021). Phytogenic fabrication of Ag-Fe bimetallic nanoparticles for cell cycle arrest and apoptosis signaling pathways in Candida auris by generating oxidative stress. Antioxidants (Basel), 10(2), 182. https://doi.org/10.3390/antiox10020182
  19. Khan, A., Moni, S. S., Ali, M., Mohan, S., Jan, H., Rasool, S., Kamal, M. A., Alshahrani, S., Halawi, M., & Alhazmi, H. A. (2022). Antifungal activity of plant secondary metabolites on Candida albicans: an updated review. Current Molecular Pharmacology, 16(1), 15-42. https://doi.org/10.2174/1874467215666220304143332
  20. Liñán-Atero, R., Aghababaei, F., Garcia, S. R., Hasiri, Z., Ziogkas, D., Moreno, A., & Hadidi, M. (2024). Clove essential oil: chemical profile, biological activities, encapsulation strategies, and food applications. Antioxidants, 13(4), 488. https://doi.org/10.3390/antiox13040488
  21. Lu, M., Li, T., Wan, J., Li, X., Yuan, L., & Sun, S. (2017). Antifungal effects of phytocompounds on Candida species alone and in combination with fluconazole. International Journal of Antimicrobial Agents, 49(2), 125-136. https://doi.org/10.1016/j.ijantimicag.2016.10.021
  22. Malik, M. A., Batterjee, M. G., Kamli, M. R., Alzahrani, K. A., Danish, E. Y., & Nabi, A. (2022). Polyphenol-capped biogenic synthesis of noble metallic silver nanoparticles for antifungal activity against Candida auris. Journal of Fungi (Basel), 8(6), 639. https://doi.org/10.3390/jof8060639
  23. Manohar, V., Ingram, C., Gray, J., Talpur, N. A., Echard, B. W., Bagchi, D., & Preuss, H. G. (2001). Antifungal activities of origanum oil against Candida albicans. Molecular and cellular biochemistry, 22(8), 111117. https://doi.org/10.1023/A:1013311632207
  24. Mare, A. D., Ciurea, C. N., Man, A., Mareș, M., Toma, F., Berța, L., & Tanase, C. (2021). In vitro antifungal activity of silver nanoparticles biosynthesized with beech bark extract. Plants (Basel), 10(10), 2153. https://doi.org/10.3390/plants10102153
  25. Martins, K. W., & Ernst, E. (2004). Herbal medicines for treatment of fungal infections: a systematic review of controlled clinical trials. Mycoses, 47(1), 8792. https://doi.org/10.1046/j.1439-0507.2003.00951.x
  26. Meirelles, G., & Ruppelt, B. M. (2023). Exploração da biodiversidade brasileira como fonte de insumos farmacêuticos ativos vegetais (IFAVs): desafios da indústria farmacêutica nacional. Revista Fito, 17(2), 236-256. https://doi.org/10.32712/2446-4775.2023.1440
  27. Ostrosk, E. L., Mizumoto, M. K., Lima, E. L. L., Kaneko, M., Nishikawa, S. O., & Freitas, B. R. (2008). Methods for evaluation of the antimicrobial activity and determination of minimum inhibitory concentration (MIC) of plant extracts. Revista Brasileira de Farmacognosia, 18(2), 301-307. https://doi.org/10.1590/S0102-695X2008000200026
  28. Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016). Rayyan: a web and mobile app for systematic reviews. Systematic Reviews, 5, 210. https://doi.org/10.1186/s13643-016-0384-4
  29. Padmapriya, G. A. A., Amshavathani, S. K., & Percy, Q. (2015). Molecular confirmation of Candida species using self-designed primers by PCR. International Journal of Current Microbiology and Applied Sciences. 4(5), 289-290.
  30. Palmeira-de-Oliveira, A., Salgueiro, L., Palmeira-de-Oliveira, R., Martinez-de-Oliveira, J., Pina-Vaz, C., Queiroz, J. A., & Rodrigues, A. G. (2009). Anti-Candida activity of essential oils. Mini reviews in medicinal chemistry, 9(11), 1292-1305. https://doi.org/10.2174/138955709789878150
  31. Perez, C. B. C., & Clímaco, E. C. (2023). Candida auris: a new, globally emerging pathogen. Interdisciplinary Journal of Health and Education, 4(2), 171-202. https://doi.org/10.56344/2675-4827.v4n2a2023.9
  32. Pinto, C., Loureiro, I., & Borges-Ferro, A. (2024). Natural oils as substitutes for the use of xylene in the clearing stage of histological processing: systematic literature review. Biomedical Laboratory Sciencer. 2(2), 311. https://doi.org/10.13140/RG.2.2.31857.90724
  33. Piasecka, A., Jedrzejczak-Rey, N., & Bednarek, P. (2015). Secondary metabolites in plant innate immunity: conserved function of divergent chemicals. New Phytologist, 206(3), 948-964. https://doi.org/10.1111/nph.13325
  34. R Core Team. (2023). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. Available from: https://www.R-project.org
  35. Raj, S., Vinod, V., Jayakumar, J., Suresh, P., Kumar, A., & Biswas, R. (2021). Antifungal activity of Syzygium samarangense leaf extracts against Candida. Letters in Applied Microbiology, 73(1), 31-38. https://doi.org/10.1111/lam.13471
  36. Rosato, R., Napoli, E., Granata, G., Di Vito, M., Garzoli, S., Geraci, C., Rizzo, S., Torelli, R., Sanguinetti, M., & Bugli, F. (2023). Study of the chemical profile and anti-fungal activity against Candida auris of Cinnamomum cassia essential oil and of its nano-formulations based on polycaprolactone. Plants, 12(2), 358. https://doi.org/10.3390/plants12020358
  37. Satoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., & Yamaguchi, H. (2009). Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiology and Immunology, 53, 41-44. https://doi.org/10.1111/j.1348-0421.2008.00083.x
  38. Shaban, S., Patel, M., & Ahmad, A. (2020). Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida auris. Scientific reports, 10(1), 1162. https://doi.org/10.1038/s41598-020-58203-3
  39. Silva, C. E. L. S., Ferreira, B. P., Lalucci-Silva, M. P. P., Lordani, T. V. A., Silva, R. C. L., Monich, M. S. T., Teixeira, J. J. V., & Lonardoni, M. V. C. (2020). Effect of essential oils on Leishmania amazonensis: a systematic review. Parasitology. 147(13), 1392-1407. https://doi.org/10.1017/S0031182020001304
  40. Smith, J. A., Taori, S. K., Schelenz, S., Jeffery, K., Johnson, E. M., Borman, A., Manuel, R., & Brown, C. S. (2017). Candida auris: a review of the literature. Clinical Microbiology Reviews. 31(1), e00029-17. https://doi.org/10.1128/cmr.00029-17
  41. Tran, H. N. H., Graham, L., & Adukwu, E. (2020). In vitro antifungal activity of Cinnamomum zeylanicum bark and leaf essential oils against Candida albicans and Candida auris. Applied Microbiology and Biotechnology. 104, 8911-8924. https://doi.org/10.1007/s00253-020-10829-z
  42. Turner, S A. & Butler, G. (2014). The Candida pathogenic species complex. Cold Spring Harbor perspectives in medicine. 4(9), a019778. https://doi.org/10.1101/cshperspect.a019778
  43. Wadaan, M. A., Baabbad, A., Khan, M. F., Saravanan, M., & Anderson, A. (2023). Phytochemical profiling, anti-hyperglycemic, antifungal, and radicals scavenging potential of crude extracts of Athyrium asplenioides – an in-vitro approach. Environmental Research, 231, 116129. https://doi.org/10.1016/j.envres.2023.116129
  44. Zapata-Zapata, C., Loaiza-Oliva, M., Martínez-Pabón, M. C., Stashenko, E. E., & Mesa-Arango, A. C. (2022). In vitro activity of essential oils distilled from Colombian plants against Candida auris and other Candida species with different antifungal susceptibility profiles. Molecules, 27(20), 6837. https://doi.org/10.3390/molecules27206837

Descargas

Los datos de descargas todavía no están disponibles.